Shui Liu Selected Research

Clostridium perfringens theta-toxin

1/2020	Amentoflavone Attenuates Clostridium perfringens Gas Gangrene by Targeting Alpha-Toxin and Perfringolysin O.
1/2020	Verbascoside Protects Mice From Clostridial Gas Gangrene by Inhibiting the Activity of Alpha Toxin and Perfringolysin O.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shui Liu Research Topics

Disease

9	Infections 05/2020 - 03/2015
6	Neoplasms (Cancer) 01/2022 - 01/2018
4	Hepatocellular Carcinoma (Hepatoma) 08/2020 - 01/2018
3	Hemolysis 01/2020 - 05/2015
2	Gas Gangrene (Gangrene, Gas) 01/2020 - 01/2020
2	Pneumonia (Pneumonitis) 12/2019 - 01/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Hypesthesia (Numbness) 05/2020
1	Hyperesthesia 05/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 05/2020
1	Paresthesia (Dysesthesia) 05/2020
1	Brain Diseases (Brain Disorder) 05/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2019
1	Colorectal Neoplasms (Colorectal Cancer) 04/2019
1	Liver Neoplasms (Liver Cancer) 08/2018
1	Hematologic Neoplasms (Hematological Malignancy) 08/2018
1	Epilepsy (Aura) 01/2018
1	Inflammation (Inflammations) 01/2017
1	Chronic Pain 01/2017
1	Staphylococcal Pneumonia 01/2017

Drug/Important Bio-Agent (IBA)

2	Therapeutic UsesIBA 01/2022 - 01/2020
2	Virulence Factors (Pathogenicity Factors)IBA 01/2020 - 03/2015
2	Clostridium perfringens theta-toxinIBA 01/2020 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 04/2019 - 01/2018
2	Listeria monocytogenes hlyA protein (listeriolysin O)IBA 01/2019 - 03/2015
2	Carbapenems (Carbapenem Antibiotics)IBA 12/2018 - 01/2018
2	Hemolysin Proteins (Hemolysins)IBA 01/2017 - 08/2015
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2021
1	Long Noncoding RNAIBA 08/2020
1	Metronidazole (Metric)FDA LinkGeneric 05/2020
1	amentoflavoneIBA 01/2020
1	BiflavonoidsIBA 01/2020
1	acteosideIBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	MicroRNAs (MicroRNA)IBA 04/2019
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 04/2019
1	TensinsIBA 04/2019
1	Competitive Endogenous RNAIBA 01/2019
1	Circular RNAIBA 01/2019
1	magnololIBA 12/2018
1	Meropenem (Merrem)FDA LinkGeneric 12/2018
1	Neoplasm Antigens (Tumor Antigens)IBA 08/2018
1	Chimeric Antigen ReceptorsIBA 08/2018
1	Colistin (Coly-Mycin)FDA Link 01/2018
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018
1	Streptococcus pneumoniae plY proteinIBA 01/2017
1	Antidepressive Agents (Antidepressants)IBA 01/2017
1	Analgesics (Analgesic Drugs)IBA 01/2017
1	baicalinIBA 01/2017
1	osthol (osthole)IBA 01/2017
1	Bacterial Proteins (Bacterial Protein)IBA 01/2017
1	PhloretinIBA 08/2015
1	fisetinIBA 05/2015
1	AntitoxinsIBA 05/2015
1	FlavonoidsIBA 05/2015

Therapy/Procedure

5	Therapeutics 12/2019 - 05/2015
2	Immunotherapy 01/2022 - 08/2018
1	Chemoradiotherapy 01/2020
1	Intraperitoneal Injections 01/2018
1	Punctures 01/2017